PT  - JOURNAL ARTICLE
AU  - Rasmussen, Sarah D
TI  - A convergence based assessment of relative differences in age-stratified susceptibility and infectiousness for SARS-CoV-2 variants of B.1.1.7 lineage
AID  - 10.1101/2021.03.18.21253931
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.18.21253931
4099  - http://medrxiv.org/content/early/2021/03/20/2021.03.18.21253931.short
4100  - http://medrxiv.org/content/early/2021/03/20/2021.03.18.21253931.full
AB  - We propose (a) a method for aggregating and processing age-stratified subregional time series data for positive tests of infection given partial sampling for variant-of-concern biomarkers, and (b) a simple model-based theoretical framework for interpreting these processed data, to assess whether observed heterogeneity in age-specific relative differences can be explained by environmental effects alone.We then apply this strategy to public-domain subregional time series data with S-gene target failure (SGTF) sampling as a proxy for B.1.1.7 lineage, from weeks 45 to 50 of 2020 from England. For the time period in question, we observe convergence toward a 1.27 (95% CI 1.17-1.38) times higher ratio of SGTF to non-SGTF infection for 0-9-year-olds than for the total population, and a 1.16 (95% CI 1.09-1.23) times higher ratio for 10-19-year-olds. These are roughly comparable to previous findings, but this time we find high-significance evidence for adequate compatibility with our proposed modelling framework criteria to conclude that these relative elevations for 0-19-year-olds are very unlikely to be explained by environmental effects alone. We also find possible indications that 0-19-year-olds might experience a higher relative increase in infectiousness than susceptibility for B.1.1.7.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis material is based upon work supported by the National Science Foundation under Grant No. DMS-1926686.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Modelling paper based on public domain data; no ethical approval required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code for this project will be made available at https://github.com/SarahDRasmussen/b117age.git https://github.com/SarahDRasmussen/b117age.git